side effects of microdosing semaglutide There isn't enough data to confirm that GLP-1s can help you live longer, says UNC Hospitals clinical pharmacist practitioner Anne Komé. But it could help clinicians optimize therapy for patients who More Than a Third of
Description
[DOI] [PubMed] [Google Scholar] 866.Mabilleau G., Gobron B., Mieczkowska A., Perrot R., Chappard D
Resources: Fahad S
(Translated using DeepL with additional editing by Mads Oddershede)
In trials, around 86% of individuals on GLP-1 agonists experience nausea or diarrhea, versus just 31% on placebo
Sumida Y, Yoneda M, Hyogo H, et al
Those using GLP-1 medications solely for weight management (without diabetes) are not at risk for diabetic retinopathy progression, though they should report any visual symptoms promptly given the ongoing investigation of rare non-retinopathy eye events
